Exact Mass: 491.2591
Exact Mass Matches: 491.2591
Found 500 metabolites which its exact mass value is equals to given mass value 491.2591
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
DB-065692
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents
Epothilone D
Lidoflazine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(-)-(trans-4-alpha-L-Rhamnosyloxy-3-methoxycinnamoyl)epilupinine
(-)-(cis-4-alpha-L-Rhamnosyloxy-3-methoxycinnamoyl)epilupinine
6beta,7beta,14beta-trihydroxy-1alpha,20-{[4-(acetylamino)butane-1,1-diyl]dioxy}-7alpha,20-epoxy-ent-kaur-16-en-15-one|hebeirubescensin A
Ala His His Lys
Ala His Lys His
Ala Lys His His
Cys Glu Ile Lys
Cys Glu Lys Ile
Cys Glu Lys Leu
Cys Glu Leu Lys
Cys Ile Glu Lys
Cys Ile Lys Glu
Cys Ile Arg Thr
Cys Ile Thr Arg
Cys Lys Glu Ile
Cys Lys Glu Leu
Cys Lys Ile Glu
Cys Lys Lys Asn
Cys Lys Leu Glu
Cys Lys Asn Lys
Cys Leu Glu Lys
Cys Leu Lys Glu
Cys Leu Arg Thr
Cys Leu Thr Arg
Cys Asn Lys Lys
Cys Arg Ile Thr
Cys Arg Leu Thr
Cys Arg Thr Ile
Cys Arg Thr Leu
Cys Thr Ile Arg
Cys Thr Leu Arg
Cys Thr Arg Ile
Cys Thr Arg Leu
Asp Lys Met Val
Asp Lys Val Met
Asp Met Lys Val
Asp Met Val Lys
Asp Val Lys Met
Asp Val Met Lys
Glu Cys Ile Lys
Glu Cys Lys Ile
Glu Cys Lys Leu
Glu Cys Leu Lys
Glu Ile Cys Lys
Glu Ile Lys Cys
Glu Lys Cys Ile
Glu Lys Cys Leu
Glu Lys Ile Cys
Glu Lys Leu Cys
Glu Leu Cys Lys
Glu Leu Lys Cys
Phe Ile Asn Val
Phe Ile Val Asn
Phe Lys Pro Thr
Phe Lys Thr Pro
Phe Leu Asn Val
Phe Leu Val Asn
Phe Asn Ile Val
Phe Asn Leu Val
Phe Asn Val Ile
Phe Asn Val Leu
Phe Pro Lys Thr
Phe Pro Gln Thr
Phe Pro Thr Lys
Phe Pro Thr Gln
Phe Gln Pro Thr
Phe Gln Thr Pro
Phe Gln Val Val
Phe Thr Lys Pro
Phe Thr Pro Lys
Phe Thr Pro Gln
Phe Thr Gln Pro
Phe Val Ile Asn
Phe Val Leu Asn
Phe Val Asn Ile
Phe Val Asn Leu
Phe Val Gln Val
Phe Val Val Gln
Gly Pro Arg Tyr
Gly Pro Tyr Arg
Gly Arg Pro Tyr
Gly Arg Tyr Pro
Gly Tyr Pro Arg
Gly Tyr Arg Pro
His Ala His Lys
His Ala Lys His
His His Ala Lys
His His Lys Ala
His Lys Ala His
His Lys His Ala
Ile Cys Glu Lys
Ile Cys Lys Glu
Ile Cys Arg Thr
Ile Cys Thr Arg
Ile Glu Cys Lys
Ile Glu Lys Cys
Ile Phe Asn Val
Ile Phe Val Asn
Ile Lys Cys Glu
Ile Lys Glu Cys
Ile Lys Met Thr
Ile Lys Thr Met
Ile Met Lys Thr
Ile Met Gln Thr
Ile Met Thr Lys
Ile Met Thr Gln
Ile Asn Phe Val
Ile Asn Val Phe
Ile Gln Met Thr
Ile Gln Thr Met
Ile Arg Cys Thr
Ile Arg Thr Cys
Ile Ser Ser Trp
Ile Thr Cys Arg
Ile Thr Lys Met
Ile Thr Met Lys
Ile Thr Met Gln
Ile Thr Gln Met
Ile Thr Arg Cys
Ile Val Phe Asn
Ile Val Asn Phe
Lys Ala His His
Lys Cys Glu Ile
Lys Cys Glu Leu
Lys Cys Ile Glu
Lys Cys Lys Asn
Lys Cys Leu Glu
Lys Cys Asn Lys
Lys Asp Met Val
Lys Asp Val Met
Lys Glu Cys Ile
Lys Glu Cys Leu
Lys Glu Ile Cys
Lys Glu Leu Cys
Lys Phe Pro Thr
Lys Phe Thr Pro
Lys His Ala His
Lys His His Ala
Lys Ile Cys Glu
Lys Ile Glu Cys
Lys Ile Met Thr
Lys Ile Thr Met
Lys Lys Cys Asn
Lys Lys Asn Cys
Lys Leu Cys Glu
Lys Leu Glu Cys
Lys Leu Met Thr
Lys Leu Thr Met
Lys Met Asp Val
Lys Met Ile Thr
Lys Met Leu Thr
Lys Met Thr Ile
Lys Met Thr Leu
Lys Met Val Asp
Lys Asn Cys Lys
Lys Asn Lys Cys
Lys Pro Phe Thr
Lys Pro Thr Phe
Lys Thr Phe Pro
Lys Thr Ile Met
Lys Thr Leu Met
Lys Thr Met Ile
Lys Thr Met Leu
Lys Thr Pro Phe
Lys Val Asp Met
Lys Val Met Asp
Leu Cys Glu Lys
Leu Cys Lys Glu
Leu Cys Arg Thr
Leu Cys Thr Arg
Leu Glu Cys Lys
Leu Glu Lys Cys
Leu Phe Asn Val
Leu Phe Val Asn
Leu Lys Cys Glu
Leu Lys Glu Cys
Leu Lys Met Thr
Leu Lys Thr Met
Leu Met Lys Thr
Leu Met Gln Thr
Leu Met Thr Lys
Leu Met Thr Gln
Leu Asn Phe Val
Leu Asn Val Phe
Leu Gln Met Thr
Leu Gln Thr Met
Leu Arg Cys Thr
Leu Arg Thr Cys
Leu Thr Cys Arg
Leu Thr Lys Met
Leu Thr Met Lys
Leu Thr Met Gln
Leu Thr Gln Met
Leu Thr Arg Cys
Leu Val Phe Asn
Leu Val Asn Phe
Met Asp Lys Val
Met Asp Val Lys
Met Ile Lys Thr
Met Ile Gln Thr
Met Ile Thr Lys
Met Ile Thr Gln
Met Lys Asp Val
Met Lys Ile Thr
Met Lys Leu Thr
Met Lys Thr Ile
Met Lys Thr Leu
Met Lys Val Asp
Met Leu Lys Thr
Met Leu Gln Thr
Met Leu Thr Lys
Met Leu Thr Gln
Met Gln Ile Thr
Met Gln Leu Thr
Met Gln Thr Ile
Met Gln Thr Leu
Met Arg Ser Val
Met Arg Val Ser
Met Ser Arg Val
Met Ser Val Arg
Met Thr Ile Lys
Met Thr Ile Gln
Met Thr Lys Ile
Met Thr Lys Leu
Met Thr Leu Lys
Met Thr Leu Gln
Met Thr Gln Ile
Met Thr Gln Leu
Met Val Asp Lys
Met Val Lys Asp
Met Val Arg Ser
Met Val Ser Arg
Asn Cys Lys Lys
Asn Phe Ile Val
Asn Phe Leu Val
Asn Phe Val Ile
Asn Phe Val Leu
Asn Ile Phe Val
Asn Ile Val Phe
Asn Lys Cys Lys
Asn Lys Lys Cys
Asn Leu Phe Val
Asn Leu Val Phe
Asn Val Phe Ile
Asn Val Phe Leu
Asn Val Ile Phe
Asn Val Leu Phe
Pro Phe Lys Thr
Pro Phe Thr Lys
Pro Gly Arg Tyr
Pro Gly Tyr Arg
Pro Lys Phe Thr
Pro Lys Thr Phe
Pro Arg Gly Tyr
Pro Arg Tyr Gly
Pro Thr Phe Lys
Pro Thr Phe Gln
Pro Thr Lys Phe
Pro Thr Gln Phe
Pro Val Asn Tyr
Pro Val Tyr Asn
Pro Tyr Gly Arg
Pro Tyr Asn Val
Pro Tyr Arg Gly
Pro Tyr Val Asn
Gln Phe Pro Thr
Gln Phe Thr Pro
Gln Phe Val Val
Gln Ile Met Thr
Gln Ile Thr Met
Gln Leu Met Thr
Gln Leu Thr Met
Gln Met Ile Thr
Gln Met Leu Thr
Gln Met Thr Ile
Gln Met Thr Leu
Gln Pro Phe Thr
Gln Thr Ile Met
Gln Thr Leu Met
Gln Thr Met Ile
Gln Thr Met Leu
Gln Val Phe Val
Gln Val Val Phe
Arg Cys Ile Thr
Arg Cys Leu Thr
Arg Cys Thr Ile
Arg Cys Thr Leu
Arg Gly Pro Tyr
Arg Gly Tyr Pro
Arg Ile Cys Thr
Arg Ile Thr Cys
Arg Leu Cys Thr
Arg Leu Thr Cys
Arg Met Ser Val
Arg Met Val Ser
Arg Pro Gly Tyr
Arg Pro Tyr Gly
Arg Ser Met Val
Arg Ser Val Met
Arg Thr Cys Ile
Arg Thr Cys Leu
Arg Thr Ile Cys
Arg Thr Leu Cys
Arg Val Met Ser
Arg Val Ser Met
Arg Tyr Gly Pro
Arg Tyr Pro Gly
Ser Met Arg Val
Ser Met Val Arg
Ser Arg Met Val
Ser Arg Val Met
Ser Val Met Arg
Ser Val Arg Met
Ser Trp Ser Leu
Thr Cys Ile Arg
Thr Cys Leu Arg
Thr Cys Arg Ile
Thr Cys Arg Leu
Thr Phe Lys Pro
Thr Phe Pro Lys
Thr Ile Cys Arg
Thr Ile Lys Met
Thr Ile Met Lys
Thr Ile Met Gln
Thr Ile Gln Met
Thr Ile Arg Cys
Thr Lys Phe Pro
Thr Lys Ile Met
Thr Lys Leu Met
Thr Lys Met Ile
Thr Lys Met Leu
Thr Lys Pro Phe
Thr Leu Cys Arg
Thr Leu Lys Met
Thr Leu Met Lys
Thr Leu Met Gln
Thr Leu Gln Met
Thr Leu Arg Cys
Thr Met Ile Lys
Thr Met Ile Gln
Thr Met Lys Ile
Thr Met Lys Leu
Thr Met Leu Lys
Thr Met Leu Gln
Thr Met Gln Ile
Thr Met Gln Leu
Thr Pro Phe Lys
Thr Pro Lys Phe
Thr Gln Ile Met
Thr Gln Leu Met
Thr Gln Met Ile
Thr Gln Met Leu
Thr Arg Cys Ile
Thr Arg Cys Leu
Thr Arg Ile Cys
Thr Arg Leu Cys
Val Asp Lys Met
Val Asp Met Lys
Val Phe Ile Asn
Val Phe Leu Asn
Val Phe Asn Ile
Val Phe Asn Leu
Val Phe Gln Val
Val Phe Val Gln
Val Ile Phe Asn
Val Ile Asn Phe
Val Lys Asp Met
Val Lys Met Asp
Val Leu Phe Asn
Val Leu Asn Phe
Val Met Asp Lys
Val Met Lys Asp
Val Met Arg Ser
Val Met Ser Arg
Val Asn Phe Ile
Val Asn Phe Leu
Val Asn Ile Phe
Val Asn Leu Phe
Val Pro Asn Tyr
Val Pro Tyr Asn
Val Gln Phe Val
Val Gln Val Phe
Val Arg Met Ser
Val Arg Ser Met
Val Ser Met Arg
Val Ser Arg Met
Val Ser Thr Trp
Val Ser Trp Thr
Val Thr Ser Trp
Val Thr Trp Ser
Val Val Phe Gln
Val Val Gln Phe
Val Trp Ser Thr
Val Trp Thr Ser
Val Tyr Asn Pro
Val Tyr Pro Asn
Trp Ile Ser Ser
Trp Leu Ser Ser
Trp Ser Ile Ser
Trp Ser Leu Ser
Trp Ser Ser Ile
Tyr Gly Pro Arg
Tyr Gly Arg Pro
Tyr Pro Gly Arg
Tyr Pro Arg Gly
Tyr Arg Gly Pro
Tyr Arg Pro Gly
ibha#18
A 4-O-(1H-indol-3-ylcarbonyl)ascaroside that is icas#18 in which the pro-R hydrogen beta to the carboxy group is replaced by a hydroxy group. It is a metabolite of the nematode Caenorhabditis elegans.
ibho#18
An omega-hydroxy fatty acid ascaroside that is bhos#18 in which the hydroxy group at position 4 of the ascarylopyranose moiety has been has been converted to the corresponding 1H-indole-3-carboxylate ester. It is a metabolite of the nematode Caenorhabditis elegans.
TERT-BUTYL ((2S,3R)-4-(4-AMINO-N-ISOBUTYLPHENYLSULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMATE
(3R)-11-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxyundecanoic acid
(3R,10R)-10-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]-3-hydroxyundecanoic acid
Lidoflazine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(1R,2S,4R,5R,8R,9S,11S)-2-[[(2R,3S,4S,5S,6R)-3,4-dihydroxy-5-methoxy-6-methyloxan-2-yl]oxymethyl]-9-formyl-5-methyl-13-propan-2-yltetracyclo[7.4.0.02,11.04,8]tridec-12-ene-1-carboxylate
(13E)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione
cyclopropyl-[(1R)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
3-[[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
N-[(2R,4aS,12aS)-5-methyl-2-[2-(4-methylanilino)-2-oxoethyl]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]cyclobutanecarboxamide
N-[(2R,4aS,12aR)-2-[2-(cyclopentylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]benzamide
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[oxo(3-pyridinyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
[(1R)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone
[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
3-[[[(2S,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
3-[[[(2R,3S)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
3-[[[(2S,3R)-8-(2-cyclopropylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-[oxo(3-pyridinyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
[(1S)-2-(cyclopropylmethyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-fluorophenyl)methanone
cyclopropyl-[(1S)-1-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-[oxo(pyridin-4-yl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
2-(dimethylamino)-1-[(1S)-1-(hydroxymethyl)-7-methoxy-1-[oxo(pyridin-4-yl)methyl]-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-(4-oxanylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
2-[2,3-Di(trimethylsilyloxy)butoxy]-N-[2-(dimethylamino)ethyl]-4-quinolinecarboxamide
Epothilone D
An epithilone that is epithilone C in which the hydrogen at position 13 of the oxacyclohexadec-13-ene-2,6-dione macrocycle has been replaced by a methyl group. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent D050258 - Mitosis Modulators > D050256 - Antimitotic Agents > D050257 - Tubulin Modulators D000970 - Antineoplastic Agents > D050256 - Antimitotic Agents
phosphatidylethanolamine 18:2 zwitterion
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and 2 double bonds.
PE(18:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PC(15:2)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved